Does ENZALUTAMIDE Cause Dysphonia? 133 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 133 reports of Dysphonia have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.3% of all adverse event reports for ENZALUTAMIDE.
133
Reports of Dysphonia with ENZALUTAMIDE
0.3%
of all ENZALUTAMIDE reports
6
Deaths
23
Hospitalizations
How Dangerous Is Dysphonia From ENZALUTAMIDE?
Of the 133 reports, 6 (4.5%) resulted in death, 23 (17.3%) required hospitalization.
Is Dysphonia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 133 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Dysphonia?
FLUTICASONE\SALMETEROL (1,729)
CABOZANTINIB S-MALATE (1,229)
ADALIMUMAB (1,216)
BUDESONIDE\FORMOTEROL (1,204)
FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (1,143)
ALBUTEROL (1,114)
LENVATINIB (1,021)
FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (943)
LENALIDOMIDE (931)
AMIKACIN (914)
Which ENZALUTAMIDE Alternatives Have Lower Dysphonia Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE